Sudarshan Pharma Updates on Proposed Stake Acquisition in Med Therapy Biotechnology
Sudarshan Pharma Industries Ltd 路 Others (Uncategorized) 路 15 Sept 2026, 7:43 pm
Sudarshan Pharma Updates on Proposed Stake Acquisition in Med Therapy Biotechnology Sudarshan Pharma Industries announced that its proposal to acquire a 9.50% equity stake in USA-based Med Therapy Biotechnology Inc. remains under due diligence, pending board resolutions and final confirmation from Med Therapy's Board of Directors. Concurrently, proposals for company promoters Hemal Mehta (CMD) and Sachin Mehta (Joint MD) to acquire a 1.50% equity stake each are also undergoing due diligence and awaiting board approval. The company stated these were preliminary intimations and further updates will be disclosed once progress is finalized.
Original exchange filing (PDF)
More announcements from Sudarshan Pharma Industries Ltd
- Pursuant to Regulation 30 and other applicable Regulations, if any, of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we inform .... 路 09 Nov 2026
- In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we hereby submit the updated Investor .... 路 07 Nov 2026
- In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising .... 路 31 Oct 2026
- This is to inform you that the Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to .... 路 30 Oct 2026
- We are submitting herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- We are submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- Sudarshan Pharma Industries Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Fund raising. 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and Fund Raising 路 29 Oct 2026
